HomeIndicesFOCMID

F

BSE Focused Midcap

FOCMID Share Price

BSE

23,569.74

106.00 (0.45%)profit
1D

Last Updated on 20 Aug 2025 at 17:00

TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

FOCMID Performance

Markets Today

High

23,619.07

Low

23,422.55

Open at

23,497.53

Prev Close

23,463.74

Volumes

0

Avg Price

0.00

Lower Circuit

0.00

Upper Circuit

0.00

Last Traded Details

Quantity

0

Time

17:00:01

Price Movement

23,422.55
23,569.74
23,619.07
Loss 0.63%down side
up side0.21% profit

Historical Performance

3 M High

24,132.28

3 M Low

22,583.39

1 Yr High

24,132.28

1 Yr Low

22,583.39

3 Yr High

24,132.28

3 Yr Low

22,583.39

5 Yr High

24,132.28

5 Yr Low

22,583.39

1-Year Performance

22,583.39
23,569.74
24,132.28
loss0.63%down side
up side0.21% profit

Market Insights

Positive Stocks

10

Negative Stocks

10

Neutral Stocks

0


FOCMID Latest News

Dixon Technologies Block Trade Worth Rs 28.61 Crores Executed on NSE

sentiment_img

A block trade involving Dixon Technologies was executed on the National Stock Exchange for approximately 16,811 shares at a price of Rs 17,021 per share. The total transaction value amounted to Rs 28.61 crores.

5 hours ago

Aurobindo Pharma Denies $5.5 Billion Zentiva Acquisition Reports

sentiment_img

Aurobindo Pharma has denied reports regarding a $5.5 billion acquisition of Zentiva, stating that no binding agreement has been reached between the companies.

7 hours ago

Lupin Launches Bosentan Tablets in US Market with 180-Day Exclusivity

sentiment_img

Lupin Limited launched Bosentan Tablets for Oral Suspension, 32 mg in the United States market. The launch follows approval received by Lupin's alliance partner NATCO Pharma Limited from the U.S. FDA for its Abbreviated New Drug Application. NATCO holds exclusive first-to-file status and will have 180-day generic drug exclusivity. The tablets are bioequivalent to Tracleer Tablets for Oral Suspension and are indicated for treating pulmonary arterial hypertension in pediatric patients aged 3 years and older. Bosentan Tablets had estimated annual sales of USD 10 million in the U.S. according to IQVIA data.

8 hours ago

SRF Partners With Chemours For Fluoropolymer Manufacturing, Revenue Growth Expected From FY27

sentiment_img

SRF Ltd. has entered a strategic partnership with Chemours Co. to manufacture fluoropolymers and fluoroelastomers at its Dahej facility. Production is expected to begin within 12 months, with revenue growth anticipated from fiscal 2027. The products serve semiconductor, automotive, aerospace, and oil and gas industries. SRF will leverage its manufacturing capabilities while Chemours provides technology, with no upfront capital investment required from Chemours. The partnership will utilize SRF's existing 5 kilotonnes per annum PTFE facility, which currently operates at 50-60% capacity. PTFE accounts for 3-4% of SRF's chemicals segment revenues. Analyst ratings vary: Citi maintains 'sell' with Rs 2,725 target, UBS maintains 'sell' with Rs 2,400 target, while DAM Capital maintains 'buy' with Rs 3,521 target. SRF shares closed 0.35% higher at Rs 2,929.6, having gained 31% over the past 12 months.

10 hours ago

Aurobindo Pharma Emerges as Frontrunner for $5.5 Billion Zentiva Acquisition

sentiment_img

Aurobindo Pharma has become the leading candidate to acquire Prague-based generic drugmaker Zentiva for $5-5.5 billion from Advent International. The deal would mark the largest acquisition by an Indian pharmaceutical company, surpassing previous records. Aurobindo is competing with US private equity firm GTCR in advanced negotiations. The company has secured a $4.75 billion credit line from MUFG as bridge financing, with the remaining $800 million from internal funds. Zentiva generated 1.7 billion euros in revenue for 2024 with 400 million euros EBITDA and operates in 30 countries. The acquisition would significantly expand Aurobindo's European presence, particularly in Eastern Europe markets including Czech Republic, Romania, and Slovakia. Aurobindo's market value stands at Rs 63,684.90 crore, while its European business grew 16.6% to Rs 8,356 crore. A formal announcement is expected within the next fortnight to month.

12 hours ago

View More


FOCMID Technicals

Moving Averages

PeriodSimpleSignal
5-SMA23,216.74Bullish
10-SMA23,017.57Bullish
20-SMA23,142.53Bullish
50-SMA0.00Bullish
100-SMA0.00Bullish
200-SMA0.00Bullish

Technical Indicators

IndicatorValueAction
RSI(14)56.26Neutral
ATR(14)292.54Less Volatile
STOCH(9,6)70.89Neutral
STOCH RSI(14)100.00Overbought
MACD(12,26)77.57Bullish
ADX(14)30.78Strong Trend

Summary of Technical Indicators for FOCMID


FOCMID Companies

FOCMID Gainers
LTP
Change%
Weightage
Market Cap (Cr.)
PE Ratio
52W High
52W Low

C

Colgate Palmolive

2,356.70

3.64%3.843%₹ 61,835.9044.393,893.002,151.00

C

Coforge

1,708.60

3.39%3.435%₹ 55,270.6057.562,003.591,190.84

I

Indus Towers

349.05

2.69%5.574%₹ 89,684.309.40460.70312.65

P

Persistent Systems

5,345.70

2.10%5.090%₹ 81,898.9053.926,788.804,163.80

C

Cummins

3,818.90

1.90%6.464%₹ 1,04,005.4048.733,926.602,594.75

N

Info Edge

1,393.60

1.00%5.560%₹ 89,464.9088.221,838.991,151.45

T

Tube Investment

3,182.90

1.00%3.791%₹ 60,997.0093.874,807.052,400.05

P

PB FinTech

1,921.20

0.43%5.463%₹ 87,897.30232.732,254.951,312.10

H

Hero Motocorp

5,135.65

0.34%6.362%₹ 1,02,372.0020.326,245.003,322.60

Y

Yes Bank

19.36

0.05%3.772%₹ 60,686.8022.2424.8416.02

FOCMID Sector Weightage

View All Sector arrow
Sectors
Companies
Weightage
Market Cap (Cr.)

Banks

413.88%2,23,331.20

Consumer Goods

210.20%1,64,073.40

Automobiles

210.15%1,63,369.00

Healthcare

29.52%1,53,195.10

Information Technology

28.52%1,37,169.50

Capital Markets

17.60%1,22,334.90

Industrial Products

16.46%1,04,005.40

Capital Goods

16.43%1,03,488.10

Telecom

15.57%89,684.30

Retail

15.56%89,464.90

Financial Services

15.46%87,897.30

Chemicals

15.40%86,840.60

Petroleum Products

15.23%84,176.70

FOCMID Share Price History

Close Price

Volume

FOCMID share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
19 Aug 202523,315.5723,463.74
0.64% profit
23,486.5823,181.940
18 Aug 202523,105.6523,215.08
0.47% profit
23,349.3723,105.650
14 Aug 202522,962.0322,887.76
-0.32% Loss
23,025.2222,865.110
13 Aug 202522,850.9422,947.36
0.42% profit
22,990.4522,833.230
12 Aug 202522,933.1622,786.34
-0.64% Loss
22,981.1122,772.460
11 Aug 202522,646.9422,846.30
0.88% profit
22,877.0822,583.390
08 Aug 202523,019.8522,665.25
-1.54% Loss
23,040.1522,640.910
07 Aug 202522,660.6623,036.68
1.66% profit
23,082.7022,652.980
06 Aug 202523,009.2322,757.48
-1.09% Loss
23,013.5822,698.560
05 Aug 202523,124.3122,973.35
-0.65% Loss
23,128.9422,877.960

FOCMID Historical Returns

Year Jan Feb MarAprMayJun JulAugSepOctNovDecAnnually

2025

0.00%-3.72%1.44%NANANANANANANANANA0.00%

FOCMID Investment Returns

1 Week

1 Month

3 Month

6 Month

9 Month

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


FOCMID Comparison
Broad Based Indices
Sectoral Indices
Name
LTP
Change
Change %arrow
1M Returns
3M Returns
6M Returns
1Y Returns
3Y Returns
5Y Returns

B

BSE Focused Midcap

₹ 23,569.74

106.000.45%-1.78%0.99%0.99%0.99%0.99%0.99%

N

Nifty Midcap Select

₹ 12,999.80

91.500.71%-2.26%3.31%14.12%1.02%79.51%68.02%

S

Sensex Next 50 Index

₹ 84,276.77

394.960.47%-0.58%3.15%12.55%-0.88%71.42%71.64%

N

NIFTY Midcap 150

₹ 21,566.10

99.250.46%-1.96%4.36%14.17%0.17%87.70%237.00%

N

Nifty Next 50

₹ 68,164.30

256.850.38%-0.49%3.02%11.67%-7.85%61.00%146.19%

N

NIFTY Smallcap 250

₹ 17,064.50

58.050.34%-4.62%4.25%15.56%-3.77%90.45%67.00%

N

NIFTY 500

₹ 23,143.15

76.550.33%-1.01%2.47%11.10%-0.59%54.27%147.02%

B

BSE 100

₹ 26,266.23

82.510.32%-0.31%1.74%9.71%0.29%46.85%129.25%

B

BSE 500

₹ 36,323.56

112.230.31%-0.99%2.28%10.89%-1.20%51.82%144.13%

N

NIFTY 100

₹ 25,689.30

76.000.30%-0.22%1.75%9.73%-0.36%44.38%123.79%

N

Nifty 50

₹ 25,050.55

69.900.28%-0.16%1.49%9.33%1.42%43.22%121.45%

S

Sensex

₹ 81,857.84

213.450.26%-0.42%0.83%8.08%1.31%39.28%114.17%

FOCMID Performers
Outperformers
Underperformers
Name
LTP
Change%arrow
High
Low

B

BSE Focused Midcap

₹ 23,569.74

0.45%₹ 23,619.07₹ 23,422.55

C

Colgate Palmolive

₹ 2,356.70

3.64%₹ 2,364.95₹ 2,264.20

C

Coforge

₹ 1,708.60

3.39%₹ 1,721.20₹ 1,632.85

I

Indus Towers

₹ 349.05

2.69%₹ 355.00₹ 341.50

P

Persistent Systems

₹ 5,345.70

2.10%₹ 5,369.35₹ 5,207.80

C

Cummins

₹ 3,818.90

1.90%₹ 3,833.90₹ 3,735.20

I

Info Edge

₹ 1,393.60

1.00%₹ 1,398.85₹ 1,364.50

T

Tube Investment

₹ 3,182.90

1.00%₹ 3,252.50₹ 3,138.65

Corporate Action of FOCMID Stocks

22nd Aug 2025, Friday

F

Federal Bank

Event

Dividend

LTP (1D Chg%)

₹ 203.42 (-0.30%)

Details

Final Dividend of ₹1.2 Per Share

The above dates are ex-dates.

View All Stock Events arrow




FAQs

There are 20 companies in BSE Focused Midcap as on 20 Aug 2025 at 17:00.
The current price of BSE Focused Midcap is ₹23,569.74 as on 20 Aug 2025 at 17:00.
The past returns of BSE Focused Midcap as on 20 Aug 2025 at 17:00 are -
  • Past 1 year: 0.99%
  • Past 3 years: 0.99%
  • Past 5 years: 0.99%
The cumulative market capitalization of all the companies listed in BSE Focused Midcap stands at ₹ 16,09,030.40 Cr. as on 20 Aug 2025 at 17:00.
No, you cannot buy BSE Focused Midcap directly. However, you can trade futures and options of 5 NSE Indices (NIFTY, BANKNIFTY, FINNIFTY, MIDCPNIFTY and NIFTY NEXT 50) and 2 BSE Indices (BSE Sensex and BSE Bankex) at the moment.
Yes, you can individually purchase the stocks of BSE Focused Midcap on Dhan using Dhan trading app or web trading platform.
You can purchase the stocks of BSE Focused Midcap using Dhan's demat account. Follow the below steps if you are new to Dhan -
  1. Download the Dhan App to open a Open Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for the stock you want to buy
  5. Tap on “Buy”.
Candle bars with Screen
Invest in
FOCMID
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's #MadeForTrade

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors